Home Therapy to Reduce Office Visits for Patients with Chronic Kidney Disease and Anemia.

Autor:	Riley MV; Nurse Practitioner, Hilton Head Start, Hilton Head Island, SC.; Member of ANNA's Palmetto Chapter., Vess J; Instructor, College of Nursing, the Medical University of South Carolina, Charleston, SC., Dumas BP; Assistant Professor, College of Nursing, the Medical University of South Carolina, Charleston, SC.
Jazyk:	angličtina
Zdroj:	Nephrology nursing journal : journal of the American Nephrology Nurses' Association [Nephrol Nurs J] 2017 Jan-Feb; Vol. 44 (1), pp. 29-33.
Abstrakt:	Anemia is a common complication of chronic kidney disease (CKD) and a predictor of increased mortality. This project integrated erythropoietin-stimulating agent (ESA) with CKD care under one practice setting, co-managing anemia with CKD while reducing frequency of office visits in a rural setting. Patients self-administered their weekly dosage of erythropoietin with monthly follow-ups. As a result, office visits decreased by 56% for patients with CKD Stage 4 and by 54% for patients with CKD Stage 5. Competing Interests: The authors reported no actual or potential conflict of interest in relation to this continuing nursing education activity. (Copyright© by the American Nephrology Nurses Association.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu Plný text ve formátu PDF